GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Edwards Lifesciences Corp (STU:EWL) » Definitions » Beneish M-Score

Edwards Lifesciences (STU:EWL) Beneish M-Score : -2.13 (As of Sep. 26, 2024)


View and export this data going back to . Start your Free Trial

What is Edwards Lifesciences Beneish M-Score?

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Good Sign:

Beneish M-Score -2.13 no higher than -1.78, which implies that the company is unlikely to be a manipulator.

The historical rank and industry rank for Edwards Lifesciences's Beneish M-Score or its related term are showing as below:

STU:EWL' s Beneish M-Score Range Over the Past 10 Years
Min: -3.8   Med: -2.29   Max: -1.85
Current: -2.13

During the past 13 years, the highest Beneish M-Score of Edwards Lifesciences was -1.85. The lowest was -3.80. And the median was -2.29.


Edwards Lifesciences Beneish M-Score Historical Data

The historical data trend for Edwards Lifesciences's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Edwards Lifesciences Beneish M-Score Chart

Edwards Lifesciences Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.39 -2.32 -2.49 -2.29 -1.99

Edwards Lifesciences Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.00 -2.08 -1.99 -1.85 -2.13

Competitive Comparison of Edwards Lifesciences's Beneish M-Score

For the Medical Devices subindustry, Edwards Lifesciences's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Edwards Lifesciences's Beneish M-Score Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Edwards Lifesciences's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Edwards Lifesciences's Beneish M-Score falls into.



Edwards Lifesciences Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Edwards Lifesciences for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 0.9562+0.528 * 1.0356+0.404 * 0.9509+0.892 * 1.0752+0.115 * 0.9652
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 1.0294+4.679 * 0.0662-0.327 * 0.9264
=-2.13

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Jun24) TTM:Last Year (Jun23) TTM:
Total Receivables was €775 Mil.
Revenue was 1287.501 + 1470.344 + 1406.77 + 1387.603 = €5,552 Mil.
Gross Profit was 1022.457 + 1115.592 + 1079.492 + 1059.279 = €4,277 Mil.
Total Current Assets was €4,195 Mil.
Total Assets was €9,382 Mil.
Property, Plant and Equipment(Net PPE) was €1,610 Mil.
Depreciation, Depletion and Amortization(DDA) was €140 Mil.
Selling, General, & Admin. Expense(SGA) was €1,721 Mil.
Total Current Liabilities was €1,131 Mil.
Long-Term Debt & Capital Lease Obligation was €624 Mil.
Net Income was 340.293 + 323.748 + 339.198 + 360.651 = €1,364 Mil.
Non Operating Income was -5.667 + -41.216 + -20.449 + 3.373 = €-64 Mil.
Cash Flow from Operations was 345.124 + -49.22 + 125.262 + 385.576 = €807 Mil.
Total Receivables was €754 Mil.
Revenue was 1195.747 + 1363.266 + 1272.795 + 1332.19 = €5,164 Mil.
Gross Profit was 958.628 + 1055.513 + 1029.338 + 1075.852 = €4,119 Mil.
Total Current Assets was €3,366 Mil.
Total Assets was €8,311 Mil.
Property, Plant and Equipment(Net PPE) was €1,613 Mil.
Depreciation, Depletion and Amortization(DDA) was €135 Mil.
Selling, General, & Admin. Expense(SGA) was €1,555 Mil.
Total Current Liabilities was €1,068 Mil.
Long-Term Debt & Capital Lease Obligation was €609 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(775.158 / 5552.218) / (753.999 / 5163.998)
=0.139612 / 0.146011
=0.9562

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(4119.331 / 5163.998) / (4276.82 / 5552.218)
=0.797702 / 0.77029
=1.0356

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (4195.364 + 1609.864) / 9382.25) / (1 - (3366.181 + 1612.573) / 8310.692)
=0.381254 / 0.400922
=0.9509

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=5552.218 / 5163.998
=1.0752

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(135.369 / (135.369 + 1612.573)) / (140.437 / (140.437 + 1609.864))
=0.077445 / 0.080236
=0.9652

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(1721.382 / 5552.218) / (1555.36 / 5163.998)
=0.310035 / 0.301193
=1.0294

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((623.824 + 1130.593) / 9382.25) / ((609.365 + 1068.096) / 8310.692)
=0.186993 / 0.201844
=0.9264

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(1363.89 - -63.959 - 806.742) / 9382.25
=0.0662

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Edwards Lifesciences has a M-score of -2.13 suggests that the company is unlikely to be a manipulator.


Edwards Lifesciences Beneish M-Score Related Terms

Thank you for viewing the detailed overview of Edwards Lifesciences's Beneish M-Score provided by GuruFocus.com. Please click on the following links to see related term pages.


Edwards Lifesciences Business Description

Address
One Edwards Way, Irvine, CA, USA, 92614
Spun off from Baxter International in 2000, Edwards Lifesciences designs, manufactures, and markets a range of medical devices and equipment for advanced stages of structural heart disease. It has established itself as a leader across key products, including surgical tissue heart valves, transcatheter valve technologies, surgical clips, catheters, and monitoring systems used to measure a patient's heart function during surgery. The firm derives about 55% of its total sales from outside the U.S.